Quantitative analysis for Gossamer Bio Inc. Common Stock (GOSS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Sell (5.0) (grade F). 30 signals analyzed (26 differentiated alt-data).
GOSS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-05-05 | $0.36 | $0.33 | $0.34 |
| 2026-05-15 | $0.34 | $0.32 | $0.34 |
| 2026-05-28 | $0.21 | $0.20 | $0.21 |
| 2026-06-09 | $0.17 | $0.15 | $0.16 |
| 2026-06-22 | $0.18 | $0.16 | $0.16 |
| 2026-07-02 | $0.18 | $0.16 | $0.17 |
| 2026-07-15 | $0.17 | $0.13 | $0.16 |
| 2026-07-27 | $0.21 | $0.14 | $0.20 |
| 2026-08-06 | $0.18 | $0.17 | $0.18 |
| 2026-08-18 | $0.15 | $0.14 | $0.14 |
| 2026-08-28 | $0.17 | $0.16 | $0.17 |
| 2026-09-10 | $0.16 | $0.14 | $0.14 |
How Gossamer Bio Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Gossamer Bio Inc. Common Stock (GOSS) scores Strong Sell (5.0), and the composite conceals a 87-point disagreement between its dimensions. It is strongest on ML forecast at 88, and weakest on earnings quality at 1 and competitive moat at 1. A stock can carry ML forecast that high while competitive moat sits at 1; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| ML forecast | 88 |
| analyst consensus | 7 |
| technicals | 2 |
| earnings quality | 1 |
| competitive moat | 1 |
StoQuant analyzes 30 signals (26 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Gossamer Bio Inc. Common Stock (GOSS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/GOSS"><img src="https://stoquant.com/badge/GOSS.svg" alt="Gossamer Bio Inc. Common Stock (GOSS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.